Growth inhibition of multiresistant enterococci by interferon-γ-activated human uro-epithelial cells

Journal of Medical Microbiology

Volumn 48, Issue 10, 1999, Pages 935-941

  MacKenzie, Colin R ^a   Hucke, Christian ^a   Müller, Dorothee ^a   Seidel, Kerstin ^a   Takikawa, Osamu ^b   Däubener, Walter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; KYNURENINE; TEICOPLANIN; TRYPTOPHAN; VANCOMYCIN;

ARTICLE; ENTEROCOCCUS; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; PRIORITY JOURNAL; UROTHELIUM; WESTERN BLOTTING;

EID: 0032746256     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-10-935     Document Type: Article

References (23)

1. Suppola JP, Volin L, Valtonen VV, Vaara M. Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies. Clin Infect Dis 1996; 23: 694-697.
2. Montecalvo MA, Shay DK, Patel P et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996; 156: 1458-1462.
3. Sastry V, Brennan PJ, Levy MM et al. Vancomycin-resistant enterococci: an emerging pathogen in immunosuppressed transplant recipients. Transplant Proc 1995; 27: 954-955.
4. Endtz HP, van den Braak N, van Belkum A et al. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol 1997; 35: 3026-3031.
5. Witte W. Impact of antibiotic use in animal feeding on resistance of bacterial pathogens in humans. Ciba Found Symp 1997; 207: 61-71.
6. Stosor V, Peterson LR, Postelnick M, Noskin GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998; 158: 522-527.
7. Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia; comparison of clinical features and outcomes. Clin Infect Dis 1998; 26: 1127-1133.
8. Linden PK, Pasculle AW, Manez R et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996; 22: 663-670.
9. Pfefferkorn ER, Rebhun S, Eckel M. Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts. J Interferon Res 1986; 6: 267-279.
10. MacKenzie CR, Hadding U, Däubener W. Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci. J Infect Dis 1998; 178: 875-878.
11. MacKenzie CR, Willberg CB, Däubener W. Inhibition of group B streptococcal growth by IFN gamma-activated human glioblastoma cells. J Neuroimmunol 1998; 89: 191-197.
12. Däubener W, Wanagat N, Pilz K, Seghrouchni S, Fischer HG, Hadding U. A new, simple, bioassay for human IFN-gamma. J Immunol Methods 1994; 168: 39-47.
13. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manuel, 2nd edn. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press. 1998: 7.3-7.23.
14. Byrne Gl, Lehmann LK, Landry GJ. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inihibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 1986; 53: 347-351.
15. Nizet V, Kim KS, Stins M et al. Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun 1997; 65: 5074-5081.
16. Winram SB, Jonas M, Chi E, Rubens CE. Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells in vitro. Infect Immun 1998; 66: 4932-4941.
17. Pfefferkorn ER. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing The host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984; 81: 908-912.
18. Gisslén M, Larsson M, Norkrans G, Fuchs D, Wachter H, Hagberg L. Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection. AIDS Res Hum Retroviruses 1994; 10: 947-951.
19. Yao L, Bengualid V, Lowy FD, Gibbons JJ, Hatcher VB, Berman JW. Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression. Infect Immun 1995; 63: 1835-1839.
20. Wade JJ, Rolando N, Williams R, Casewell MW. Serious infections caused by multiply-resistant Enterococcus faecium. Microb Drug Resist 1995; 1: 241-243.
21. Jones RN, Sader HS, Erwin ME, Anderson SC. Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group. Diagn Microbiol Infect Dis 1995; 21: 85-93.
22. Handwerger S, Raucher B, Altarac D et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16: 750-755.
23. Stroud L, Edwards J, Danzing L, Culver D, Gaynes R. Risk factors for mortality associated with enterococcal bloodstream infections. Infect Control Hosp Epidemiol 1996; 17: 576-580.